GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » Total Stockholders Equity

Haleon (LSE:HLN) Total Stockholders Equity : £0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Total Stockholders Equity?

Haleon's Total Stockholders Equity for the quarter that ended in Mar. 2024 was £0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Haleon's Book Value per Share for the quarter that ended in Mar. 2024 was £N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Haleon's Debt-to-Equity for the quarter that ended in Mar. 2024 was .


Haleon Total Stockholders Equity Historical Data

The historical data trend for Haleon's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Total Stockholders Equity Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
27,321.00 26,112.00 26,355.00 16,331.00 16,606.00

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 16,450.00 - 16,606.00 -

Haleon  (LSE:HLN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Haleon's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Haleon's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haleon Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Haleon's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon (LSE:HLN) Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.